13F-HR filed by 72 Investment Holdings, LLC
72 Investment Holdings, LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 7 holding rows worth $67,080,683.
- Accession
- 0000902664-24-003613
- Filer
- CIK 1832749
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 7 entries on the cover page, a total value of $67,080,683 stated on the cover page (in dollars after the unit check, H1), rows summing to $67,080,683 with VALUE read as dollars as filed, 13F file number 028-20409. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KORRO BIO INC | 500946108 | COMMON STOCK | 276,831 | $24,914,790 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 1,017,751 | $22,726,380 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 667,778 | $10,250,392 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 65,933 | $4,023,232 | dollars as filed | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 474,067 | $2,436,704 | dollars as filed | |
| TURNSTONE BIOLOGICS CORP | 90042W100 | COM | 549,981 | $1,440,950 | dollars as filed | |
| OMEGA THERAPEUTICS INC | 68217N105 | COMMON STOCK | 352,941 | $1,288,235 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000902664-24-003613 | this filing | 2024-05-15 | acceptance time not in the bulk data set |